TABLE 3.
Baseline Characteristics
| Characteristics | PPI (n = 11,828) | Non-PPI (n = 11,828) |
|---|---|---|
| Male gender, % | 97% | 96% |
| Mean age, y | 77 | 77 |
| Depression, No. (%) | 326 (2.8) | 86 (0.7) |
| Diabetes mellitus, No. (%) | 4,486 (37.9) | 3,055 (25.8) |
| Stroke, No. (%) | 252 (2.1) | 398 (3.4) |
| Cardiovascular disease, No. (%) | 6,279 (53.1) | 3,723 (31.5) |
| Hypertension, No. (%) | 9,638 (81.5) | 7,100 (60.0) |
| Dyslipidemia, No. (%) | 9,404 (79.5) | 7,221 (61.1) |
| Hearing loss, No. (%) | 5,674 (48.0) | 1,745 (14.8) |
| Tobacco use, No. (%) | 2,527 (21.4) | 1,745 (14.8) |
| Alcohol misuse, No. (%) | 941 (8.0) | 4,50 (3.8) |
| Hemoglobin A1c, mean, % | 6.35 | 6.28 |
| Anticholinergic drug use, No. (%) | 853 (7.2) | 2,176 (18.4) |
Abbreviation: PPI, proton pump inhibitor.